The Latest De-SPAC Debacle

Casdin, Corvex, Soros, and Louis Bacon are among the victims of the latest ill-fated blank-check merger.

Bigstock photo

Bigstock photo

It is yet another de-SPAC disaster.

A pharmaceutical company that last week completed its merger with a blank-check company sponsored by two prominent hedge fund firms is the latest company to have its stock mauled.

Shares of EQRx closed Tuesday at $6.41, down more than 21 percent on the day and more than 35 percent since the stock began trading last Friday, following the company’s merger with CM Life Sciences III.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.